Related Experiment Videos
Technique for determining the bactericidal effect of drug combinations
Antimicrobial Agents and Chemotherapy
|June 1, 1974
Summary
This study shows trimethoprim and sulfamethoxazole act synergistically against most tested E. coli, Klebsiella, and Proteus mirabilis strains. The novel method effectively identifies antimicrobial synergy, even for resistant strains.
Area of Science:
- Microbiology
- Pharmacology
- Antimicrobial Resistance
Background:
- Antimicrobial combinations are crucial for treating complex infections.
- Understanding drug interactions (synergy, antagonism) is vital for effective treatment strategies.
- Assessing the efficacy of antibiotic combinations against common pathogens is an ongoing challenge.
Purpose of the Study:
- To evaluate the synergistic, additive, or antagonistic effects of antimicrobial combinations.
- To assess the efficacy of trimethoprim and sulfamethoxazole against specific bacterial strains.
- To introduce and validate a novel method for determining antimicrobial interactions.
Main Methods:
- A novel method involving filter membranes on Mueller-Hinton agar was developed.
- Paper strips with antimicrobial agents were used to diffuse antibiotics into the agar.
- Microorganisms were cultured on the membrane, then transferred to antibiotic-free agar with triphenyltetrazolium hydrochloride for growth pattern analysis.
Main Results:
- Trimethoprim and sulfamethoxazole demonstrated synergistic activity against 85% of Escherichia coli, 86% of Klebsiella, and 89% of Proteus mirabilis strains.
- The combination therapy proved effective against some strains resistant to individual agents.
- The technique successfully differentiated between synergistic, additive, and antagonistic drug effects.
Conclusions:
- Trimethoprim and sulfamethoxazole exhibit significant synergy against common Gram-negative bacteria.
- This method provides a reliable approach for evaluating antimicrobial drug combinations.
- The findings support the use of trimethoprim-sulfamethoxazole combinations in clinical settings for susceptible infections.